Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Insulin Resistance & Diabetes

Impact of perioperative management of glycemia in severely obese diabetic patients undergoing gastric bypass surgery

L. L. Chuah; A. D. Miras; D. Papamargaritis; S. N. Jackson; T. Olbers; C. W. le Roux Impact of perioperative management of glycemia in severely obese diabetic patients undergoing gastric bypass surgery Surg Obes Relat Dis
Insulin Resistance & Diabetes

Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device

J. Casella-Mariolo; L. Castagneto-Gissey; G. Angelini; A. Zoli; P. Marini; S. R. Bornstein; D. J. Pournaras; F. Rubino; C. W. le Roux; G. Mingrone; G. Casella Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device EBioMedicine
Insulin Resistance & Diabetes NAFLD

Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery

A. L. Canney; R. V. Cohen; J. A. Elliott; M. A. C; W. P. Martin; N. G. Docherty; C. W. le Roux Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery Diab Vasc Dis Res
Insulin Resistance & Diabetes

Dipeptidyl peptidase-4 activity, lipopolysaccharide, C-reactive protein, glucose metabolism, and gut peptides 3 months after bariatric surgery

T. G. Braga; M. D. Graças Coelho de Souza; M. Menezes; J. F. Nogueira Neto; L. Dellatorre-Teixeira; E. Bouskela; C. W. le Roux; L. G. Kraemer-Aguiar Dipeptidyl peptidase-4 activity, lipopolysaccharide, C-reactive protein, glucose metabolism, and gut peptides 3 months after bariatric surgery Surg Obes Relat Dis
Gut-Brain Insulin Resistance & Diabetes

Options in Bariatric Surgery: Modeled Decision Analysis Supports One-Anastomosis Gastric Bypass as the Treatment of Choice when Type 2 Diabetes Is Present

C. Brosnan; J. C. Bolger; E. M. Bolger; M. E. Kelly; R. Tully; M. AlAzzawi; W. B. Robb Options in Bariatric Surgery: Modeled Decision Analysis Supports One-Anastomosis Gastric Bypass as the Treatment of Choice when Type 2 Diabetes Is Present Obes Surg
Insulin Resistance & Diabetes

Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease

A. P. Belgaumkar; R. P. Vincent; K. A. Carswell; R. D. Hughes; J. Alaghband-Zadeh; R. R. Mitry; C. W. le Roux; A. G. Patel Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease Obes Surg
Insulin Resistance & Diabetes NAFLD

Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission

T. Arora; V. Velagapudi; D. J. Pournaras; R. Welbourn; C. W. le Roux; M. Orešič; F. Bäckhed Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission PLoS One
Insulin Resistance & Diabetes

How do patients’ clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure?

T. Bächler; C. W. le Roux; M. Bueter How do patients’ clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure? Clin Exp Gastroenterol
Insulin Resistance & Diabetes

Diabetes-associated microbiota in fa/fa rats is modified by Roux-en-Y gastric bypass

T. Arora; F. Seyfried; N. G. Docherty; V. Tremaroli; C. W. le Roux; R. Perkins; F. Bäckhed Diabetes-associated microbiota in fa/fa rats is modified by Roux-en-Y gastric bypass Isme j
Insulin Resistance & Diabetes

Continuous Glucose Monitoring of Glycemic Variability During Fasting Post-Sleeve Gastrectomy

E. Al-Ozairi; A. El Samad; J. Al Kandari; E. Taghadom; S. Adam; C. le Roux; A. A. Syed Continuous Glucose Monitoring of Glycemic Variability During Fasting Post-Sleeve Gastrectomy Obes Surg
Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 … Page30 Page31 Page32 … Page34 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2026 ASOI